Paper36937426
Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1.
Yunger S and 4 others. Front Oncol, 2023. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1. Papers, record 36937426. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937426
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,068,926 | Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/33068926 | PubMed |
| 2 | 2,138,563 | An exact comparison between the efficiency of two- and three-cell-type clusters in mediating helper activity. | Eur J Immunol | 1990 | https://conductscience.org/library/papers/2138563 | PubMed |
| 3 | 3,264,384 | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3264384 | PubMed |
| 4 | 34,010,040 | Adoptive Cellular Therapy for Solid Tumors. | Am Soc Clin Oncol Educ Book | 2021 | https://conductscience.org/library/papers/34010040 | PubMed |
| 5 | 28,420,421 | Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. | Genome Med | 2017 | https://conductscience.org/library/papers/28420421 | PubMed |
| 6 | 16,964,261 | Surface-bound chemokines capture and prime T cells for synapse formation. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16964261 | PubMed |
| 7 | 17,576,008 | Protein-polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering. | Biomaterials | 2007 | https://conductscience.org/library/papers/17576008 | PubMed |
| 8 | 32,433,532 | A guide to cancer immunotherapy: from T cell basic science to clinical practice. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/32433532 | PubMed |
| 9 | 28,222,796 | New development in CAR-T cell therapy. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28222796 | PubMed |
| 10 | 25,838,374 | Adoptive cell transfer as personalized immunotherapy for human cancer. | Science | 2015 | https://conductscience.org/library/papers/25838374 | PubMed |
| 11 | 34,112,147 | Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors. | BMC Med | 2021 | https://conductscience.org/library/papers/34112147 | PubMed |
| 12 | 20,467,460 | Chimeric antigen receptor-engineered T cells for immunotherapy of cancer. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20467460 | PubMed |
| 13 | 22,566,933 | Molecular mechanisms of treg-mediated T cell suppression. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566933 | PubMed |
| 14 | 11,581,169 | Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. | Int Immunol | 2001 | https://conductscience.org/library/papers/11581169 | PubMed |
| 15 | 21,739,672 | T cell exhaustion. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21739672 | PubMed |
| 16 | 24,258,985 | Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. | Methods Mol Biol | 2014 | https://conductscience.org/library/papers/24258985 | PubMed |
| 17 | 27,298,832 | CAR T Cell Therapy: A Game Changer in Cancer Treatment. | J Immunol Res | 2016 | https://conductscience.org/library/papers/27298832 | PubMed |
| 18 | 22,878,966 | Tumor-infiltrating lymphocytes in melanoma. | Curr Oncol Rep | 2012 | https://conductscience.org/library/papers/22878966 | PubMed |
| 19 | 31,754,328 | Current Progress in CAR-T Cell Therapy for Solid Tumors. | Int J Biol Sci | 2019 | https://conductscience.org/library/papers/31754328 | PubMed |
| 20 | 8,752,893 | Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. | J Immunol | 1996 | https://conductscience.org/library/papers/8752893 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,897,261 | Spatial polarization of endothelial ICAM-1 governs T-cell exclusion in melanoma. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42897261 | PubMed |
| 42,686,747 | T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42686747 | PubMed |
| 41,527,444 | T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41527444 | PubMed |
| 41,112,292 | Differential effects of immobilized CCL21 and ICAM1 on TILs with distinct expansion properties. | Front Immunol | 2025 | https://conductscience.org/library/papers/41112292 | PubMed |
| 38,866,588 | Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38866588 | PubMed |
| 38,515,134 | CTLs heterogeneity and plasticity: implications for cancer immunotherapy. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38515134 | PubMed |
| 38,490,212 | Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38490212 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36937426
GET https://conductscience.org/api/papers/v1/36937426/references?page=2